IRWD

MKT CAP:$570M

Ironwood Pharmaceuticals Inc

Market Cap

$570M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$3.31-$0.96 (-22.48%)

Jun 5, 2026

52W High $5.3952W Low $0.59

Company Details

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate c...

CEO

—

IPO Date

Feb 3, 2010

Website

ironwoodpharma.com

Key Metrics TTM

Revenue

$362M

+13.8% YoY

Net Income

$102M

EPS (Diluted)

Free Cash Flow

$112M

Revenue / Share

$2.17

Gross Margin

99.6%

Operating Margin

55.8%

Net Margin

28.3%

FCF Margin

31.0%

P/S

1.6x

P/E

5.6x

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 7, 2026

$107M+158.9%

FY 2025

Feb 26, 2026

$296M-15.7%

Q4 2025

Feb 26, 2026

$48M-47.3%

Q3 2025

Nov 10, 2025

$122M+33.3%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee